221 related articles for article (PubMed ID: 28437628)
21. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.
Young EW
Integr Biol (Camb); 2013 Sep; 5(9):1096-109. PubMed ID: 23799587
[TBL] [Abstract][Full Text] [Related]
22. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening.
Brooks A; Zhang Y; Chen J; Zhao CX
Adv Healthc Mater; 2024 Jan; ():e2302436. PubMed ID: 38224141
[TBL] [Abstract][Full Text] [Related]
23. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review.
Xu H; Cheng C; Le W
Electrophoresis; 2022 Apr; 43(7-8):839-847. PubMed ID: 35179796
[TBL] [Abstract][Full Text] [Related]
24. Biomaterials and Microfluidics for Drug Discovery and Development.
Carvalho MR; Truckenmuller R; Reis RL; Oliveira JM
Adv Exp Med Biol; 2020; 1230():121-135. PubMed ID: 32285368
[TBL] [Abstract][Full Text] [Related]
25. Engineering biomolecular microenvironments for cell instructive biomaterials.
Custódio CA; Reis RL; Mano JF
Adv Healthc Mater; 2014 Jun; 3(6):797-810. PubMed ID: 24464880
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms involved in breast cancer liver metastasis.
Ma R; Feng Y; Lin S; Chen J; Lin H; Liang X; Zheng H; Cai X
J Transl Med; 2015 Feb; 13():64. PubMed ID: 25885919
[TBL] [Abstract][Full Text] [Related]
27. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
28. Effect of suberoylanilide hydroxamic acid (SAHA) on breast cancer cells within a tumor-stroma microfluidic model.
Peela N; Barrientos ES; Truong D; Mouneimne G; Nikkhah M
Integr Biol (Camb); 2017 Dec; 9(12):988-999. PubMed ID: 29188843
[TBL] [Abstract][Full Text] [Related]
29. Deciphering the molecular basis of breast cancer metastasis with mouse models.
Vernon AE; Bakewell SJ; Chodosh LA
Rev Endocr Metab Disord; 2007 Sep; 8(3):199-213. PubMed ID: 17657606
[TBL] [Abstract][Full Text] [Related]
30. A microfluidic platform for modeling metastatic cancer cell matrix invasion.
Blaha L; Zhang C; Cabodi M; Wong JY
Biofabrication; 2017 Sep; 9(4):045001. PubMed ID: 28812983
[TBL] [Abstract][Full Text] [Related]
31. Lipid tethering of breast tumor cells enables real-time imaging of free-floating cell dynamics and drug response.
Chakrabarti KR; Andorko JI; Whipple RA; Zhang P; Sooklal EL; Martin SS; Jewell CM
Oncotarget; 2016 Mar; 7(9):10486-97. PubMed ID: 26871289
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral phenotypic heterogeneity as an encourager of cancer invasion.
Shin Y; Han S; Chung E; Chung S
Integr Biol (Camb); 2014 Jul; 6(7):654-61. PubMed ID: 24844199
[TBL] [Abstract][Full Text] [Related]
33. Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems.
Zheng F; Fu F; Cheng Y; Wang C; Zhao Y; Gu Z
Small; 2016 May; 12(17):2253-82. PubMed ID: 26901595
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform.
Katt ME; Placone AL; Wong AD; Xu ZS; Searson PC
Front Bioeng Biotechnol; 2016; 4():12. PubMed ID: 26904541
[TBL] [Abstract][Full Text] [Related]
35. Engineered Models of Metastasis with Application to Study Cancer Biomechanics.
Chen MB; Kamm RD; Moeendarbary E
Adv Exp Med Biol; 2018; 1092():189-207. PubMed ID: 30368754
[TBL] [Abstract][Full Text] [Related]
36. Metastasis suppressors and their roles in breast carcinoma.
Vaidya KS; Welch DR
J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):175-90. PubMed ID: 17587154
[TBL] [Abstract][Full Text] [Related]
37. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
38. Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.
Mohammadi MH; Heidary Araghi B; Beydaghi V; Geraili A; Moradi F; Jafari P; Janmaleki M; Valente KP; Akbari M; Sanati-Nezhad A
Adv Healthc Mater; 2016 Oct; 5(19):2459-2480. PubMed ID: 27548388
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
40. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
